OncoCyte Common Stock

OncoCyte (0KCC.L) currently reports a common stock of $390M as of June 2026. That compares with $370M in the prior-year period — up 7.3% year over year. Use the charts on this page to explore OncoCyte's common stock history and peer comparisons.

OncoCyte's common stock increased from $370M to $390M — a 7.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OncoCyte reported $390M in common stock as of June 2026. That compares with $370M in the prior-year period — up 7.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $390M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OncoCyte, and consider following 0KCC.L for alerts when major investors trade the stock.